Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy - Sorbonne Université Accéder directement au contenu
Article Dans Une Revue Science Translational Medicine Année : 2020

Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy

Patrick Yu-Wai-Man
Magali Taiel
Laure Blouin
  • Fonction : Auteur
Pierre Burguière
Gerard Smits
  • Fonction : Auteur
Barrett Katz
Serge Picaud

Résumé

REVERSE is a randomized, double-masked, sham-controlled, multicenter, phase 3 clinical trial that evaluated the efficacy of a single intravitreal injection of rAAV2/2-ND4 in subjects with visual loss from Leber hereditary optic neuropathy (LHON). A total of 37 subjects carrying the m.11778G>A (MT-ND4) mutation and with duration of vision loss between 6 to 12 months were treated. Each subject's right eye was randomly assigned in a 1:1 ratio to treatment with rAAV2/2-ND4 (GS010) or sham injection. The left eye received the treatment not allocated to the right eye. Unexpectedly, sustained visual improvement was observed in both eyes over the 96-week follow-up period. At week 96, rAAV2/2-ND4-treated eyes showed a mean improvement in best-corrected visual acuity (BCVA) of -0.308 LogMAR (+15 ETDRS letters). A mean improvement of -0.259 LogMAR (+13 ETDRS letters) was observed in the sham-treated eyes. Consequently, the primary end point, defined as the difference in the change in BCVA from baseline to week 48 between the two treatment groups, was not met (P = 0.894). At week 96, 25 subjects (68%) had a clinically relevant recovery in BCVA from baseline in at least one eye, and 29 subjects (78%) had an improvement in vision in both eyes. A nonhuman primate study was conducted to investigate this bilateral improvement. Evidence of transfer of viral vector DNA from the injected eye to the anterior segment, retina, and optic nerve of the contralateral noninjected eye supports a plausible mechanistic explanation for the unexpected bilateral improvement in visual function after unilateral injection.
Fichier principal
Vignette du fichier
Yu-Wai-Man et al. - 2020 - Bilateral visual improvement with unilateral gene .pdf (411.08 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03373492 , version 1 (11-10-2021)

Identifiants

Citer

Patrick Yu-Wai-Man, Nancy J Newman, Valerio Carelli, Mark L Moster, Valerie Biousse, et al.. Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy. Science Translational Medicine, 2020, 12 (573), ⟨10.1126/scitranslmed.aaz7423⟩. ⟨hal-03373492⟩
80 Consultations
806 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More